{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:05:10Z","timestamp":1790057110091,"version":"4.0.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>RAS-associated autoimmune leukoproliferative disorder (RALD) is a rare, nonmalignant lymphoproliferative disorder characterized by splenomegaly, autoimmune cytopenia, monocytosis, and somatic RAS pathway mutations. Severe hepatic failure is an uncommon manifestation. Here, we report a critically ill infant with a diagnosis of RALD who presented with fulminant liver failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>\n                      A 9-month-old girl presented with recurrent infections, lymphadenopathy, massive hepatosplenomegaly, cytopenia, coagulopathy, and early-onset liver failure. Disseminated\n                      <jats:italic>Talaromyces marneffei<\/jats:italic>\n                      infection was confirmed by two sets of peripheral blood cultures. Whole-exome sequencing (WES) identified a heterozygous\n                      <jats:italic>KRAS<\/jats:italic>\n                      c.351A&amp;gt;C (p.Lys117Asn, K117N) variant located in the GTP-binding domain. The heterozygous state and clinical context are consistent with a somatic mutation in a subset of hematopoietic cells, rather than a germline variant. The patient died two days after admission despite antibiotics and maximal supportive care, including plasma exchange and intravenous immunoglobulin.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates that RALD-associated immune dysregulation served as the underlying root cause, on the basis of which a disseminated opportunistic infection developed as the direct cause of the fatal deterioration, revealing a potential link between oncogenic RAS signaling and innate immune dysregulation. It underscores the urgency of early genetic screening in infants with unexplained hepatitis and systemic inflammation, while advocating for novel therapeutic strategies targeting RAS\/MAPK pathways.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1943641","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:38:52Z","timestamp":1790055532000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: RAS-associated autoimmune leukoproliferative disorder presenting with early-onset liver failure in a 9-month-old Chinese girl"],"prefix":"10.3389","volume":"14","author":[{"given":"Lu","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children\u2019s Hospital, School of Medicine, Shanghai Jiao Tong University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1009962","DOI":"10.1371\/journal.pcbi.1009962","article-title":"Multi-targeting of K-Ras domains and mutations by peptide and small molecule inhibitors","volume":"18","author":"Poorebrahim","year":"2022","journal-title":"PLoS Comput Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"8953","DOI":"10.1073\/pnas.0702975104","article-title":"NRAS mutation causes a human autoimmune lymphoproliferative syndrome","volume":"104","author":"Oliveira","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1182\/blood-2010-08-301515","article-title":"Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation","volume":"117","author":"Takagi","year":"2011","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/DAD.0000000000001332","article-title":"Superficial and deep cutaneous involvement by RAS-associated autoimmune leukoproliferative disease (RALD cutis): a histologic mimicker of histiocytoid sweet syndrome","volume":"41","author":"Tran","year":"2019","journal-title":"Am J Dermatopathol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/ced.13668","article-title":"Cutaneous involvement in an 8-year-old boy with Ras-associated autoimmune leucoproliferative disorder (RALD)","volume":"43","author":"Giacaman","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12969-019-0346-1","article-title":"RAS-associated autoimmune leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children","volume":"17","author":"Wang","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.12688\/f1000research.11545.1","article-title":"Autoimmune lymphoproliferative syndrome: more than a FAScinating disease","volume":"6","author":"Bride","year":"2017","journal-title":"F1000Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10875-020-00883-7","article-title":"Clinical spectrum of Ras-associated autoimmune leukoproliferative disorder (RALD)","volume":"41","author":"Neven","year":"2021","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood-2014-11-567917","article-title":"JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities","volume":"125","author":"Calvo","year":"2015","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1182\/blood-2010-07-295501","article-title":"Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis","volume":"117","author":"Niemela","year":"2011","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2014-01-548958","article-title":"RAS-associated lymphoproliferative disease evolves into severe juvenile myelo-monocytic leukemia","volume":"123","author":"Lanzarotti","year":"2014","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"300670","DOI":"10.1016\/j.hpr.2022.300670","article-title":"Histopathological and molecular findings in a patient with Ras-associated autoimmune leukoproliferative disorder","volume":"29","author":"Xie","year":"2022","journal-title":"Hum Pathol Rep"},{"key":"B14","year":""},{"key":"B15","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.3892\/ol.2017.7016","article-title":"Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancer","volume":"14","author":"Jia","year":"2017","journal-title":"Oncol Lett"},{"key":"B16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/bjh.19564","article-title":"Ras-associated autoimmune lymphoproliferative disorder","volume":"205","author":"Sullivan","year":"2024","journal-title":"Br J Haematol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev-genom-091212-153523","article-title":"The RASopathies","volume":"14","author":"Rauen","year":"2013","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","article-title":"Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects","volume":"19","author":"Vanittanakom","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1615943","DOI":"10.3389\/fped.2025.1615943","article-title":"Case report: Talaromyces marneffei infections associated with pharyngeal and laryngeal injuries in three children with aberrant innate immunity: a case series","volume":"13","author":"Zhang","year":"2025","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/myc.13295","article-title":"Talaromyces marneffei infection in non-HIV-infected patients in mainland China","volume":"64","author":"He","year":"2021","journal-title":"Mycoses"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e19185","DOI":"10.1097\/MD.0000000000019185","article-title":"Non-HIV talaromycosis: radiological and clinical analysis","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e516","DOI":"10.1097\/MPH.0000000000001276","article-title":"Weekly rituximab followed by monthly rituximab treatment for autoimmune disease associated with RAS-associated autoimmune leukoproliferative disease","volume":"40","author":"Toyoda","year":"2018","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1943641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:38:53Z","timestamp":1790055533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1943641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":22,"alternative-id":["10.3389\/fped.2026.1943641"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1943641","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1943641"}}